Aamir Amin, MD
Clinical Cardiac Electrophysiology · Arlington, TXNPI 1962611830
Payments from drug & device makers
Across 308 payments — averaging $35.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Medtronic$1K
- Philips North America LLC$811
- Boehringer Ingelheim$460
- Johnson & Johnson$454
- Sanofi-aventis U.S. LLC$431
- plus $3K from 21 others
What the payments were for
- Travel & lodging$4,72643%
- Food & beverage$6,10055%
- Education$2002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 43 | $4,871 |
| Medtronic(2 entities) | 19 | $1,002 |
| Philips North America LLC | 16 | $811 |
| Boehringer Ingelheim | 23 | $460 |
| Johnson & Johnson | 33 | $454 |
| Sanofi-aventis U.S. LLC | 22 | $431 |
| Merck | 21 | $415 |
| Biosense Webster, Inc. | 24 | $411 |
| Boston Scientific | 12 | $342 |
| Pfizer | 18 | $307 |
| AstraZeneca | 17 | $300 |
| Cvrx, Inc. | 5 | $249 |
| Novartis | 12 | $205 |
| E.r. Squibb & Sons, L.L.C. | 11 | $178 |
| Amgen | 9 | $143 |
| Vital Connect, Inc | 4 | $78 |
| Esperion Therapeutics, Inc. | 4 | $69 |
| Bardy Diagnostics, Inc. | 2 | $65 |
| Alnylam Pharmaceuticals Inc. | 3 | $65 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $44 |
| Chiesi USA, Inc. | 1 | $25 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Edwards Lifesciences | 1 | $20 |
| Atricure, Inc. | 1 | $14 |
| Altathera Pharmaceuticals LLC | 1 | $14 |
| Convatec Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$3,742
- (9520) IGT Devices Undivided$452
- Micra$283
- Barostim Neo System$175
- JOT DX$116
- AMPLATZER AMULET$112
How this compares
$11,025 in reported general payments places this provider in the 15th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 696 | $760,986 |
| EntrestoSacubitril/Valsartan | 139 | $134,655 |
| MultaqDronedarone Hcl | 117 | $125,043 |
| XareltoRivaroxaban | 93 | $89,327 |
| JardianceEmpagliflozin | 54 | $59,389 |
| FarxigaDapagliflozin Propanediol | 52 | $52,204 |
| Dofetilide | 180 | $31,722 |
| Flecainide Acetate | 311 | $10,939 |
| Metoprolol Succinate | 372 | $3,826 |
| Mexiletine Hcl | 35 | $3,017 |
| Amiodarone Hcl | 77 | $1,714 |
| Rosuvastatin Calcium | 92 | $1,476 |
| Ezetimibe | 38 | $1,356 |
| Digoxin | 52 | $1,330 |
| Atorvastatin Calcium | 106 | $1,313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $307 | $760,986696 claims |
| NovartisEntresto | $205 | $134,655139 claims |
| Sanofi-aventis U.S. LLCMultaq | $431 | $125,043117 claims |
| Johnson & JohnsonXarelto | $454 | $89,32793 claims |
| Boehringer IngelheimJardiance | $460 | $59,38954 claims |
| AstraZenecaFarxiga | $300 | $52,20452 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Arlington
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
- Michael DelaughterBedford$2.1M
- James DevillePlano$1.5M
- Robert CanbyAustin$1.5M
- Amin Al-AhmadAustin$1.4M
- Theodore TakataFort Worth$1.4M
- Miguel ValderrabanoHouston$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.